DHA Pharmaceutical Supply Chain Vulnerability Assessment
Sole-source, firm-fixed-price task order (10-week base period) for Accenture Federal Services to assess domestic onshoring options for Active Pharmaceutical Ingredients and Key Starting Materials used in combat-essential medications, 100% of which are currently sourced outside the US.
A sole-source, firm-fixed-price task order awarded by the Defense Health Agency to Accenture Federal Services, via the Defense Logistics Agency's JETS contract vehicle, to assess domestic onshoring options for the 100% foreign-sourced Active Pharmaceutical Ingredients and Key Starting Materials used in combat-essential medications. 10-week base period; contract value is officially undisclosed.
Award detail
- Agency
- Defense Health Agency (DHA) / Defense Logistics Agency JETS vehicle
- Award ID
- Ceiling value
- Undisclosed
- Vehicle
- DLA J6 Enterprise Technology Services (JETS)
- Awarded
- 2026-07-01
- Period of performance ends
Programs0
No linked records yet.
Frequently asked
- What is the DHA Pharmaceutical Supply Chain Vulnerability Assessment contract?
- A sole-source, firm-fixed-price task order awarded by the Defense Health Agency to Accenture Federal Services, via the Defense Logistics Agency's JETS contract vehicle, to assess domestic onshoring options for the 100% foreign-sourced Active Pharmaceutical Ingredients and Key Starting Materials used in combat-essential medications. 10-week base period; contract value is officially undisclosed.
- Which agency awarded the DHA Pharmaceutical Supply Chain Vulnerability Assessment contract?
- The DHA Pharmaceutical Supply Chain Vulnerability Assessment contract was awarded by Defense Health Agency (DHA) / Defense Logistics Agency JETS vehicle under a DLA J6 Enterprise Technology Services (JETS) vehicle.
Sources & citations1
Each claim links to its underlying source. Confidence reflects how directly the source supports the claim.
- 1
DHA awards Accenture Federal Services a sole-source, firm-fixed-price, 10-week task order to assess domestic pharmaceutical manufacturing onshoring options; contract value not disclosed
ExecutiveBiz: DHA Awards Accenture Sole-Source Pharma Supply Chain Assessment TaskVerified2026-07-17